Flowers Foods Inc

Latest Results (05.04.2026):

Flowers Foods Inc — fourth quarter of fiscal 2025 (13-week quarter ended January 3, 2026) and full-year fiscal 2025 results: the company reported higher net sales driven by an extra week and the Simple Mills acquisition, but a large non‑cash $136.0 million impairment of intangible assets drove a Q4 GAAP net loss; adjusted results showed stable-to-modestly weaker underlying performance and management provided a cautious 2026 outlook.

Net sales

Q4 net sales rose 11.0% to $1.233 billion (extra week, Simple Mills and price/mix offsets volume declines). Full-year 2025 net sales were $5.256 billion, up 3.0% year-over-year.

GAAP net income and major charge

Q4 net loss was $67.1 million, a decline of $110.2 million versus prior-year quarter, driven primarily by a $136.0 million non‑cash impairment of finite‑lived intangible assets. Fiscal 2025 net income was $83.8 million (down 66.2%).

Adjusted earnings and EBITDA

Q4 adjusted net income was $45.8 million (down 1.5%) and adjusted EBITDA increased 14.7% to $117.4 million (9.5% margin). For the full year, adjusted net income was $231.6 million and adjusted EBITDA was $535.2 million (10.2% margin), slightly below prior year.

Earnings per share

Q4 diluted EPS (GAAP) was a loss of $0.32 per share; adjusted diluted EPS was $0.22 (flat with prior-year quarter). Full-year diluted EPS was $0.40 and adjusted diluted EPS was $1.09 (down $0.19).

Simple Mills acquisition impact

Simple Mills contributed $57.5 million in Q4 net sales (Q4 net loss of $6.2 million), added $6.3 million to adjusted EBITDA and reduced diluted EPS by ~$0.03; for the year Simple Mills added $213.9 million in net sales and $32.0 million to adjusted EBITDA.

Cash flow, capital allocation and balance sheet

Fiscal 2025 cash flow from operations was $446.2 million (up $33.5M), capex $127.1 million, dividends paid $209.3 million. Cash and cash equivalents were $12.1 million at year end; long‑term debt rose to $1.755 billion (reflecting acquisition funding).

Other notable items

Q4 included a $2.7 million loss on inferior ingredients and higher net interest expense (up ~$11.4 million) from acquisition‑related debt and fees; production costs were 51.5% of sales and SD&A was 39.9% of sales (adjusted SD&A 39.0%).

Outlook and management actions

For fiscal 2026 management expects net sales ~$5.163B–$5.267B, adjusted EBITDA ~$465M–$495M, and adjusted diluted EPS ~$0.80–$0.90 (assumptions: D&A ~$165M–$170M, net interest ~$65M–$70M, effective tax rate ~26%, ~213.5M diluted shares). Management is conducting an operational and portfolio review to address category headwinds and one fewer week of operations.